Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat

Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3428-33. doi: 10.1073/pnas.93.8.3428.

Abstract

Marked increases in intracellular calcium may play a role in mediating cellular dysfunction and death following central nervous system trauma, in part through the activation of the calcium-dependent neutral protease calpain. In this study, we evaluated the effect of the calpain inhibitor AK295 [Z-Leu-aminobutyric acid-CONH(CH2)3-morpholine] on cognitive and motor deficits following lateral fluid percussion brain injury in rats. Before injury, male Sprague-Dawley rats (350-425 g) were trained to perform a beam-walking task and to learn a cognitive test using a Morris water maze paradigm. Animals were subjected to fluid percussion injury (2.2-2.4 atm; 1 atm = 101.3 kPa) and, beginning at 15 min postinjury, received a continuous intraarterial infusion of AK295 (120-140 mg/kg, n = 15) or vehicle (n= 16) for 48 hr. Sham (uninjured) animals received either drug (n = 5) or vehicle (n = 10). Animals were evaluated for neurobehavioral motor function at 48 hr and 7 days postinjury and were tested in the Morris water maze to evaluate memory retention at 7 days postinjury. At 48 hr, both vehicle- and AK295-treated injured animals showed significant neuromotor deficits (P< 0.005). At 7 days, injured animals that received vehicle continued to exhibit significant motor dysfunction (P< 0.01). However, brain-injured, AK295-treated animals showed markedly improved motor scores (P<0.02), which were not significantly different from sham (uninjured) animals. Vehicle-treated, injured animals demonstrated a profound cognitive deficit (P< 0.001), which was significantly attenuated by AK295 treatment (P< 0.05). To our knowledge, this study is the first to use a calpain inhibitor following brain trauma and suggests that calpain plays a role in the posttraumatic events underlying memory and neuromotor dysfunction.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain Injuries / drug therapy*
  • Brain Injuries / etiology
  • Brain Injuries / physiopathology*
  • Calpain / antagonists & inhibitors*
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / etiology
  • Cysteine Proteinase Inhibitors / administration & dosage
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Dipeptides / administration & dosage
  • Dipeptides / pharmacology*
  • Disease Models, Animal
  • Male
  • Memory / drug effects
  • Psychomotor Performance / drug effects*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Cysteine Proteinase Inhibitors
  • Dipeptides
  • AK 295
  • Calpain